Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma
Clinical trial NCT00815607 · COMPLETED
Trial details
- NCT number
- NCT00815607
- Sponsor
- Alaunos Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2013-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.